Eli Lilly and Company Dividends

The next dividend date for Eli Lilly and Company is August 14, 2026.

A dividend of $1.73 per share is scheduled.

What is a Dividend Date

When we talk about a dividend date, we’re referring specifically to the ex-dividend date.

This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.

The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.

Most brokerages will automatically credit the dividend to your account once it’s issued.

Historical Dividends for Eli Lilly and Company (LLY)

05/15/202605/04/202605/15/202606/10/2026$1.73
02/13/202612/08/202502/13/202603/10/2026$1.73
11/14/202510/27/202511/14/202512/10/2025$1.50
08/15/202506/23/202508/15/202509/10/2025$1.50
05/16/202505/05/202505/16/202506/10/2025$1.50
02/14/202512/09/202402/14/202503/10/2025$1.50
11/15/202410/28/202411/15/202412/10/2024$1.30
08/15/202406/24/202408/15/202409/10/2024$1.30
05/15/202405/06/202405/16/202406/10/2024$1.30
02/14/202412/08/202302/15/202403/08/2024$1.30
...

More About Eli Lilly and Company

Country
USA
Full Time Employees
50,000

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss for severe atopic dermatitis; Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Omvoh for ulcerative colitis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. Further, it provides Emgality for migraine prevention and episodic cluster headache, as well as Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.A. for Ebglyss; and Chugai Pharmaceutical Co., Ltd for orforglipron; strategic collaboration with Ascidian Therapeutics for development of therapies for undisclosed monogenic kidney diseases; and BioArctic AB (publ) for new treatment. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Owning Eli Lilly and Company Stock on the Dividend Date

If you own Eli Lilly and Company stock on the ex-dividend date, then you earn the associated dividend.

Theoretically, the price of Eli Lilly and Company stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Eli Lilly and Company stock).

Therefore, it is typically not expected that there is any incremental profit to be gained from buying Eli Lilly and Company stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Eli Lilly and Company dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.

Owning Eli Lilly and Company Options on the Dividend Date

Unlike the stock price, which will normally have an abrupt decrease by the amount of the dividend on the ex-dividend date, option prices typically do not reflect the same phenomenon.

The reason is that in the time leading up to the ex-dividend date, that projected drop in Eli Lilly and Company stock price from the dividend is already baked into Eli Lilly and Company option prices.

That means the prices of call options that overlap the Eli Lilly and Company ex-dividend date typically go down in the period leading up to the ex-dividend date.

The prices of put options that overlap the Eli Lilly and Company ex-dividend date typically go up in the period leading up to the ex-dividend date.

Owners of Eli Lilly and Company call options do not receive the dividend, even if they own the options on the ex-dividend date. Owners of Eli Lilly and Company put options are not responsible to pay the dividend, even if they own the options on the ex-dividend date.

Learning More Eli Lilly and Company Dividends

You can contact us any time if you would like to ask questions about Eli Lilly and Company dividends or anything else related to the stock market.